Immediate Impact

12 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Electrochemical Biosensors for Whole Blood Analysis: Recent Progress, Challenges, and Future Perspectives
2023 Standout
Prostate cancer
2021 Standout
5 intermediate papers

Works of C. Haqq being referenced

Improved survival outcomes in clinically relevant patient subgroups from COU-AA-301, a phase III study of abiraterone acetate (AA) plus prednisone (P) in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-based chemotherapy.
2011
7001 ORAL Abiraterone Acetate Improves Functional Status in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Post-docetaxel – Results From the COU-AA-301 Phase 3 Study
2011
and 4 more

Author Peers

Author Last Decade Papers Cites
C. Haqq 274 102 96 180 133 20 509
Tae Ho Hwang 233 87 21 236 90 24 521
Cristina Bilbao 62 99 33 202 78 31 447
Ines Figueiredo 345 233 92 178 38 25 552
Yasunori Harada 194 83 27 161 83 23 442
Stanislav Lechpammer 125 92 97 133 22 26 423
Neda Stjepanovic 147 195 15 149 108 27 543
Markus Mayrhofer 170 98 8 151 133 21 493
F Desangles 89 75 39 335 82 18 542
Gert Jan Fleuren 71 114 43 108 54 16 457
Jean Kao 247 64 31 280 36 11 537

All Works

Loading papers...

Rankless by CCL
2026